PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
25.52%
Revenue growth above 1.5x TSM's 2.67%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.52%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
-33.30%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-33.30%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-32.17%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.43%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-32.43%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.33%
Share change of 0.33% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.64%
Diluted share change of 0.64% while TSM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.69%
Dividend growth of 0.69% while TSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
72.39%
Positive OCF growth while TSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
79.05%
FCF growth under 50% of TSM's 176.96%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
343.12%
10Y revenue/share CAGR 1.25-1.5x TSM's 236.55%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
194.48%
5Y revenue/share CAGR above 1.5x TSM's 67.78%. David Dodd would look for consistent product or market expansions fueling outperformance.
68.02%
3Y revenue/share CAGR 1.25-1.5x TSM's 59.57%. Bruce Berkowitz might see better product or regional expansions than the competitor.
4142.41%
10Y OCF/share CAGR above 1.5x TSM's 197.04%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
744.30%
5Y OCF/share CAGR above 1.5x TSM's 75.71%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
115.41%
3Y OCF/share CAGR above 1.5x TSM's 44.44%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
510.29%
Net income/share CAGR above 1.5x TSM's 273.50% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2001.04%
5Y net income/share CAGR above 1.5x TSM's 85.31%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
3.40%
Below 50% of TSM's 85.86%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
368.66%
10Y equity/share CAGR 1.25-1.5x TSM's 250.85%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
191.99%
5Y equity/share CAGR above 1.5x TSM's 65.48%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
125.76%
3Y equity/share CAGR above 1.5x TSM's 32.88%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
64.05%
Dividend/share CAGR of 64.05% while TSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
14.22%
3Y dividend/share CAGR of 14.22% while TSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
9.28%
AR growth well above TSM's 6.44%. Michael Burry fears inflated revenue or higher default risk in the near future.
24.20%
Inventory growth well above TSM's 10.27%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.28%
Asset growth 1.25-1.5x TSM's 5.95%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.88%
BV/share growth above 1.5x TSM's 2.11%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.54%
Debt shrinking faster vs. TSM's 31.16%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
35.65%
R&D growth drastically higher vs. TSM's 0.38%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
113.99%
SG&A growth well above TSM's 16.21%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.